Related by context. All words. (Click for frequent words.) 44 Reverse Cholesterol Transport 44 BCT 42 OMT 42 SGLT 41 Pharmacokinetic studies 40 NOD mouse 40 prucalopride 40 DAPT 40 randomisation 40 subconjunctival injection 39 MRTF 39 peptide conjugated 39 ETT 39 intravenous dosing 39 IFN α 38 SHIL 38 Fenretinide 38 PPMO 38 BMP 38 ancrod 38 antitrypsin 38 MiTT 38 CCL2 38 anecortave acetate 38 intradermal injections 38 pharmacodynamic PD 38 Zilver PTX stent 38 fludarabine cyclophosphamide 38 vidofludimus 38 neuropathy sparing 37 NOX E# 37 ENGAGE AF TIMI 37 GAMMAGARD 37 LCP Tacro TM 37 Mechanised Infantry 37 EBCC 37 intraperitoneally 37 SGLT2 inhibitors 37 randomized controlled Phase 37 BTT 37 hemangioblast 37 BSTB 37 octreotide 37 1st MLG FWD 37 Pharmaceutical Profiles 37 Diamyd R 37 ELR 37 Ultratrace 37 orally dosed 37 adenoviral vectors 37 GW# [003] 37 ASSERT 37 LB# [003] 37 caspase inhibitor 37 LT NS# 36 RE MODEL 36 untreated multiple myeloma 36 IIIA NSCLC 36 PTMA 36 multicenter randomized controlled 36 double blinded randomized 36 CSSB 36 Enzastaurin 36 ABCG1 36 basal bolus regimen 36 Madras Regiment 36 CALGB 36 therapy Diamyd 36 solithromycin 36 Randomised 36 receptor antagonism 36 NCT 36 PRT 36 PCMT 36 osteopathic manipulative treatment 36 pharmacokinetic PK study 36 subcutaneously administered 36 adefovir dipivoxil 36 ARG# 36 OvaRex MAb 36 NN# [001] 36 deferoxamine 36 Kahalalide F 36 somatostatin analog 36 FOCALIN XR 36 randomized discontinuation 36 androgen blockade 36 B2A 36 nutlin 35 Xelox 35 OPCAB 35 MAG 35 Xanafide 35 SCR 35 Sirolimus eluting 35 GHK 35 splenocytes 35 REALITY Trial 35 NSABP 35 Accordion Pill 35 analgesic efficacy 35 DU #b 35 Vascugel ® 35 ConclusionThis 35 mITT population 35 PDE4 inhibitor 35 intradermal injection 35 BCIRG 35 Leuprolide 35 Dismounted 35 morpholino 35 Janus Kinase 35 Zosano 35 Phase Ib study 35 RIFLES 35 Palletline 35 sirolimus eluting stents 35 TAXUS ATLAS 35 quantitative computed tomography 35 cytoreductive nephrectomy 35 Janus kinase 35 PRECiSE 35 rFVIIIFc 35 ANG 35 concurrent chemoradiation 35 Randomized Evaluation 35 prospective multicenter 35 fosbretabulin 35 CALGB # [002] 35 MPTS 35 G#DT 35 ORMD 35 Pgp 35 multicenter phase 35 CIPN 35 dabigatran etexilate 35 Serruys 35 GCSF 35 MAGE 35 #IB 35 PEGylated 35 paclitaxel carboplatin 35 thyroid hormone receptor 35 MVA MUC1 IL2 35 chemokine receptor 35 radiolabeled 34 M# HMMWV 34 JMRC 34 Aplidin 34 ZACTIMA 34 Elitek 34 ADVANCE PD 34 factorial design 34 direct thrombin inhibitors 34 MoxDuo 34 tinzaparin 34 CoFactor 34 Neurostep TM 34 GlcNAc 34 Dabigatran etexilate 34 DLTs 34 PC DAC Exendin 34 Qutenza TM 34 AZD 34 TAXOTERE R 34 NCT# ClinicalTrials.gov 34 IRESSA 34 Redox 34 pegylated liposomal doxorubicin 34 TAXUS V 34 coadministration 34 paricalcitol 34 conformal radiotherapy 34 EDEMA3 34 FDG-PET/CT 34 Hypersil GOLD 34 azacytidine 34 hematopoietic progenitor cells 34 EOquin TM 34 euglycemic clamp 34 bevacizumab Avastin ® 34 MSCT 34 RDA 34 deoxy 34 Interferon alfa 34 NP2 34 TLR2 34 CD3 monoclonal antibody 34 volociximab 34 LCP Tacro 34 SBMC 34 HHV 34 Alvesco R 34 integrin alpha 34 DCCR 34 rFactor XIII 34 sitagliptin phosphate 34 laquinimod 34 CERE 34 StemEx R 34 neoadjuvant 34 APEX PD 34 Parathyroid Hormone 34 Ceplene/IL-2 34 cleavable linker 34 PLGA 34 Intec Pharma 34 E1 INT TM 34 Fibroblast Growth Factor Receptor 34 ritonavir boosted 34 Phase 1a clinical 34 gene inactivation 34 standard chemotherapy regimen 34 Cellvizio R 34 Derived Factor 34 melphalan prednisone 34 azilsartan medoxomil 34 RAV# 34 YONDELIS 34 Traficet EN 34 Appendix VII 34 intra arterial 34 selective adenosine 34 ASCT 34 lysophosphatidic acid 34 Endovenous 34 Mucosal 34 superoxide dismutase 34 somatostatin analogue 34 immunotherapeutic vaccine 34 StemEx 34 OIF 34 KSRP platoons 34 GLP1 agonist 34 HBCT 34 SYN# 34 Galectin 34 selective antagonist 33 Phase III randomized controlled 33 insulin detemir 33 abiraterone acetate 33 AZOR 33 papillary thyroid carcinoma 33 Henley Tn 33 murine monoclonal antibody 33 Sandostatin LAR 33 GOUT 33 CLD 33 A2A receptor 33 Endarterectomy 33 P selectin 33 Endovascular System 33 Viralytics 33 goserelin 33 Annexin 33 soluble receptor 33 NANT 33 selectively inhibiting 33 Neurologix gene 33 syngeneic 33 VEGFR1 33 topically administered 33 ESBC 33 Oxford Immunotec 33 Leukotriene 33 RLY# 33 WS2 33 Ophena 33 antifibrotic 33 PQR 33 interleukin 33 phase IIa clinical 33 Nuron Biotech 33 ELACYT 33 glycosaminoglycan 33 TMC# C# 33 NCIC CTG 33 preclinical efficacy 33 Gorkha Rifles 33 liposomal formulation 33 EBUS TBNA 33 PROTEGE 33 hexose 33 Cloretazine R VNP#M 33 randomizing patients 33 TNF α 33 tipranavir 33 HQA 33 Litx 33 Beale AFB Calif. 33 Cardiosonix 33 Resten NG 33 Annexin V 33 Dyloject TM 33 SOCS3 33 Medidata Designer 33 IntroductionThe 33 trodusquemine 33 thermosensitive 33 Aptivus ® 33 Countermine 33 rhBMP 2 33 stem cell transplantations 33 Refractory Angina 33 mediated inhibition 33 reteplase 33 immunofluorescence staining 33 co trimoxazole 33 Vesicular 33 IDET 33 WPPL 33 TASQ 33 RE LY ® 33 dnaJP1 33 Alocrest 33 Anticalin ® 33 Oxygent 33 Telmisartan 33 eluting stent 33 darunavir ritonavir 33 tumor antigen 33 cell adhesion molecule 33 Neupogen ® 33 targeted muscle reinnervation 33 PrevOnco ™ 33 Ceflatonin R 33 dose escalation phase 33 HCV SPRINT 33 viral kinetic 33 administered subcutaneously 33 Kamada AAT 33 interstitial brachytherapy 33 canakinumab 33 AAV 33 TransMID 33 Anticalins ® 33 Aplidin R 33 PEGylated interferon 33 TRO# 33 RESOLUTE 33 oral talactoferrin 33 Aeroquin 33 CureVac 33 CTAP# Capsules 33 HQC 33 immunoreactive 33 BioMatrix 33 dorsal root ganglion 33 KKW 33 ImmuKnow R 33 RTOG 33 AESOP 33 conjugate vaccines 33 including eniluracil ADH 33 ROCKET AF 33 aminolevulinic acid 33 BLP# Liposome Vaccine 33 Bendamustine 33 Dabigatran 33 Preclinical studies indicate 33 LH RH 33 HuMax EGFr 33 multicentre randomized controlled 33 mcg dose 33 GSK# [001] 33 inotropic 33 5 hydroxytryptamine 33 #th RQW 33 Comparators 33 lentiviral 33 multiprotein 33 blinded randomized 33 prospective randomized multicenter 33 independent prognostic marker 32 receptor blocker 32 cortical stimulation 32 IL2 32 DermaPrep 32 VerifyNow 32 papillary RCC 32 extranodal 32 RAR 32 pitavastatin 32 Haematology Oncology 32 platelet inhibitor 32 Granulocyte Colony Stimulating Factor 32 RezularTM 32 multikinase inhibitor 32 IVMD 32 Cytochrome P# 32 muscarinic 32 IRadimed 32 CCX# B 32 non nucleoside 32 ReN# 32 Intramuscular 32 proteasome inhibitor bortezomib 32 OC# [001] 32 oncolytic vaccine 32 MWT 32 EchoCRT 32 pelvic lymphadenectomy 32 Velindre Hospital 32 beta 1a 32 transthoracic echocardiography 32 TNFa 32 transfemoral 32 metaplasia 32 REYATAZ ® 32 DSEK 32 DEB# 32 GnRH antagonist 32 REVEAL Registry 32 endovascular interventions 32 transient transfection 32 Spine Patient Outcomes 32 NO# [002] 32 dose dependently 32 Shahid Niaz 32 Assault Battalion 32 immunomodulatory therapy 32 HCV Genotype 32 Potent Inhibitor 32 TLIF 32 IFN alpha 2a 32 phosphatidylinositol 32 MLSD 32 NHS Kirklees 32 Symadex 32 multicentre randomized 32 SGLT2 inhibitor 32 #:# randomization 32 CLSS 32 PhotoThera 32 ERalpha 32 CTC 32 randomized Phase IIb 32 adducts 32 LentiVector 32 striatal dopamine 32 Prosaptide 32 IncreaseRx 32 Cropredy Res 32 EGS# 32 MICARDIS ® 32 inhaled treprostinil 32 ARB telmisartan 32 nab paclitaxel 32 TNF receptors 32 benign neoplasms 32 PTS 32 BCTP 32 ERK1 2 32 lentiviral vector 32 Ferriprox 32 phase IIIb 32 cannabinoid receptor 32 VentrAssist LVAD 32 Telatinib 32 miglustat 32 SoloVir TM ETS 32 pyridyl 32 Humeral 32 GSTP1 32 cytochrome c oxidase 32 ONTARGET 32 HORIZONS AMI trial 32 Changchun Railway 32 CRMP 32 Syllego system 32 LCP AtorFen 32 Irinotecan 32 BioNumerik 32 ARRC 32 Current Controlled Trials 32 CHRE 32 pain palliation 32 sodium chondroitin sulfate 32 BAY #-# 32 MedTrust 32 multicenter prospective 32 cytokeratin 32 Phase #/#a 32 darunavir 32 Phase III psoriasis 32 IL 1ß 32 DermaVir Patch 32 NIR Diagnostics 32 Sibia 32 Tomographic 32 Phase Ib clinical 32 Bellicum 32 T2A 32 PET CT scanning 32 XYOTAX TM 32 trastuzumab DM1 T DM1 32 Arno Therapeutics 32 lorcaserin Phase 32 Interlink M# 32 substrate specificity 32 HMRI 32 MYTHOS trial 32 everolimus eluting stents 32 Oncoscience AG 32 HBeAg + 32 pT2 32 PSTC 32 double blinded placebo 32 PEY 32 ibandronate 32 CBLC# 32 Vernakalant 32 adrenergic receptors 32 atrial natriuretic peptide 32 Central Venous Catheter 32 UroVysion 32 immatics 32 quadrature amplitude modulation QAM 32 pharmacokinetics PK 32 IMPACT DCM clinical 32 TG# [001] 32 DMD DMSc 32 treatment naive genotype 32 WRAIR 32 Apidra ® 32 prospective randomized 32 adenoviral 32 BPS IC 32 BrachySil TM 32 apical 32 Mpex 32 NAVISTAR R 31 Association BEVA 31 VDF 31 inhaled AAT 31 CDK 31 NSABP B 31 Regimental Centre 31 NS3 31 KRN# 31 Liprostin 31 Rosemary Thew 31 LPV r 31 CRRT 31 Augment Injectable 31 WILEX 31 GPIIb IIIa 31 dose escalation Phase 31 SMTs 31 ,#,# [002] 31 AFRS 31 cTnI 31 multimodality therapy 31 Phase IIIb clinical 31 multivariate Cox 31 OMS# 31 Novozymes Biopharma 31 JVX 31 Sym# 31 TroVax ® 31 Fontan procedure 31 LANTUS ® 31 chimeric monoclonal antibody 31 Cinacalcet HCl 31 mimetic peptide 31 CORD II 31 SEPET TM 31 ExCell study 31 ERCP 31 pioglitazone HCl 31 regorafenib 31 EVEREST II 31 placebo controlled randomized 31 #rd Explosive Ordnance 31 AmpliMed 31 RhuDex ® 31 CZP 31 NLX P# 31 coronary stenting 31 randomized clinical 31 M Vax 31 locoregional disease 31 CIMZIA TM 31 HDACi 31 AOD# [002] 31 Lucentis ranibizumab Genentech 31 Efficacy endpoints included 31 Curacyte AG 31 Gliadel Wafer 31 Kupffer cells 31 Lysis 31 antibody MAb 31 JKAP 31 ACE Inhibitor 31 multicentre randomized double 31 NK1 31 antibody titres 31 clevidipine 31 Facet Solutions 31 Moxifloxacin 31 Liposomal 31 mononuclear 31 ELISA kit 31 liver transplant recipients 31 Ceftaroline 31 aqueous formulation 31 randomized #:#:# 31 Innocoll Technologies 31 cyclosporin 31 immunomodulating agents 31 laparoscopic radical nephrectomy 31 Vertos 31 intraperitoneal 31 randomized multicenter 31 darunavir r 31 defibrotide 31 osteocalcin protein 31 Simotion 31 comparator arm 31 multicenter Phase 31 placebo controlled clinical 31 CCL# 31 deoxyglucose 31 HIRA 31 Genz # 31 BrachySil ™ 31 oncologic outcomes 31 GRN# 31 Convivia TM 31 placebo controlled Phase III 31 oral iron chelator 31 EndoTAG TM -1 31 ADAGIO study 31 Factor VIIa 31 phase IIb clinical 31 CA9 SCAN 31 prospective nonrandomized 31 intravenously administered 31 TACP 31 kinase pathway 31 controlled multicenter Phase 31 OAQ 31 StrataGraft 31 AMD# [003] 31 glycosyltransferase 31 MZO 31 havildar 31 GHRH 31 multicenter randomized placebo controlled 31 Phase IIb III 31 HYLENEX recombinant 31 lymphadenectomy 31 nitric oxide synthase NOS 31 postoperative morbidity 31 IFNa 31 plasminogen activator inhibitor 31 Aclidinium 31 activin 31 thrombin receptor 31 BANES 31 CRp 31 EtherNet 31 CSTC 31 Monocyte 31 Subcutaneous 31 Detect Ready 31 NMES 31 Fig. 1D 31 urocortin 2 31 Scancell 31 Kirkee 31 JAKLI 31 SCS 31 Mycophenolate Mofetil 31 CAV 31 Proxinium TM 31 sutureless 31 Dynabeads 31 N acetyl 31 Aflibercept 31 Castleland 31 docetaxel Taxotere ® 31 glycogen synthase kinase 31 carboxypeptidase 31 ALT 31 β1 31 Myelodysplastic Syndrome MDS 31 Tacrolimus 31 APTIVUS 31 protein tyrosine phosphatase 31 pamidronate 31 Spectral EAA TM 31 Instanyl 31 eculizumab therapy 31 BCCH 31 Reductase 31 esterification 31 proprietary Anticalin 31 Contingency Operating Base Adder 31 cytokines IL 31 Allovectin 7 31 selective A1 adenosine 31 Trovax 31 NR 31 QOPI 31 AFRS TM 31 EoPDH 31 metastatic RCC 31 SPIRIVA R 31 KN# [001] 31 endoluminal 31 Initiated Phase 31 EUFLEXXA R 31 BMP2 31 QFT 31 Tg mice 31 phase Ib 31 CIMIC 31 β2 31 Intradermal 31 Orqis Medical 31 Melphalan 31 bortezomib Velcade R 31 multicenter randomized 31 Phase Ib II 31 VEGF receptor 31 Welwyn Components 31 focal adhesion kinase FAK 31 valve implantation 31 transcriptional regulation 31 Micardis ® 31 PEG interferon 31 enGene 31 intraventricular 31 constipation predominant IBS 31 FGF 31 paragangliomas 31 Edoxaban 31 Specialist Registrar 31 Avvio Networks 31 Eg5 30 DASC 30 ProstaScint 30 Aurora Kinase 30 Cambridge Temperature Concepts 30 GWR 30 Pepscan 30 Vandana Disodia 30 DCFA 30 thrombocytopenic patients 30 Chronic Total Occlusions 30 Onconova 30 Tryton 30 ACTIVE W 30 tumorigenicity 30 Abatacept 30 caspase 30 voltage divider 30 EGb 30 metastatic neuroendocrine tumors 30 RAPAFLO 30 RCMC 30 tesmilifene 30 BFT 30 LADS 30 antiretroviral naïve 30 Vascugel 30 #F ML 30 CitySprint 30 glucose transporter 30 CHAMPION PCI 30 D Dimer 30 ABSORB trial 30 Campath alemtuzumab 30 interleukin IL 30 TRSS 30 basolateral 30 zalutumumab 30 CAX 30 platelet activating 30 indocyanine green 30 pertussis toxin 30 Inhaled AAT 30 bone morphogenic protein 30 Dalbavancin 30 Panzer Elite 30 daily subcutaneous injections 30 HZW 30 NeuroVive 30 RARC 30 TNFR 30 DuraHeart TM 30 NeoDisc 30 RG# MRAP 30 Anticoagulation 30 adrenergic receptor 30 Aquamid 30 MDR1 30 CellExSys 30 pro angiogenic 30 levosimendan 30 PROCHYMAL 30 Optivia 30 Aloxi injection 30 pelvic lymph node dissection 30 Gigabit Optical 30 Alagebrium 30 HT 1A 30 Cellgate 30 Combat Identification 30 S1P 30 C#BL 6 mice 30 proline rich 30 SPT 30 monocyte chemotactic protein 30 PD2i 30 SETAF 30 PSMs 30 allogenic 30 servo amplifiers 30 Endo PAT 30 Teysuno 30 CROSSER 30 Graphnet 30 LC#m# 30 Western blotting 30 TheraSphere 30 HS2 Ltd 30 Antibody Discovery 30 Humalog ® 30 LPS induced 30 diagnostic modality 30 pT3 30 coactivator 30 SERCA2a 30 EndoTAG 30 transduced 30 ZYBRESTAT TM 30 peripheral arterial 30 Sydenhams 30 HyACT 30 microdose 30 MIST II 30 electrograms 30 IPL# 30 thymic 30 Engerix B 30 5 HT2A 30 Vacc 4x 30 SIR Spheres 30 G CSF 30 dSLIM 30 DEEP AF 30 Nanobody 30 RX ACCULINK 30 transcranial 30 osteoinductive 30 OLYMPIA registry 30 cytotoxic conjugate 30 Inflazyme 30 platelet gel 30 Medidur FA 30 Phase IIA 30 Adsorption 30 ADP receptor antagonist 30 transvaginal sonography 30 generation rotary VAD 30 BENCHMRK 30 Mammostrat 30 Julietta Patnick director 30 GMCP 30 OneSAF 30 RELIANT trial 30 Teikoku Seiyaku Co. 30 lorvotuzumab mertansine 30 landmark ATHENA trial 30 Proximion 30 SIMPADICO 30 ANTIBODY 30 Î ² 30 Accelovance 30 pharmacologic intervention 30 Hybridon 30 Chemophase 30 Confocal microscopy 30 P2X 30 AEGR 30 trabeculectomy 30 selective agonists 30 Adhibit 30 TCT 30 limbal stem cell 30 EXCITE 30 MVax 30 stated Michelle Berrey 30 Wrexham Maelor 30 MVax ® 30 OMP #M# 30 Innate Immune 30 CCTT 30 IIMAK 30 MyoCell 30 ActiveMine ™ 30 Taxus Liberté 30 RLN 30 celgosivir 30 PEG INTRON R 30 Gamida 30 biologic DMARD 30 Solesta 30 Myeloid 30 virological response 30 SVH 30 armored HMMWV 30 Pharm Olam 30 Multiple Ascending Dose 30 Circulating Tumor Cell 30 Endeavor drug eluting 30 transthoracic 30 Mipomersen 30 HCS 30 BST CarGel 30 lysophosphatidic acid LPA 30 α 30 astrocytic 30 cathepsin K inhibitor 30 mitochondrial depolarization 30 Common Toxicity Criteria 30 BRIM2 30 Stanes 30 Cloretazine 30 serpin 30 receptor monoclonal antibody 30 XIENCE V stent 30 PRH 30 induced apoptosis 30 blinded randomized controlled 30 NTx R 30 Induction Chemotherapy 30 randomized #:# 30 ZYBRESTAT fosbretabulin 30 APTIVUS R 30 sunitinib malate 30 transforaminal 30 Mimpara 30 Solulin 30 p = #.# [003] 30 ARCOM 30 ceftazidime 30 EPMA 30 Xerecept 30 amino terminus 30 RLT 30 ^ sup ^ 30 fibrin glue 30 confirmatory Phase III 30 TSX VENTURE OMT 30 PLND 30 Dr Gillian Braunold 30 PREOS R 30 Hardide 30 PREZISTA ritonavir 30 Quinamed 30 enzyme phosphodiesterase 30 Stromal 30 Transferrin 30 Faraday Plastics 30 PE1 30 Percutaneous Transluminal Coronary Angioplasty 30 blind multicenter 30 9S 30 Pujar 30 MPEP 30 Recombinant Human 30 INT# [002] 30 Balloon Sinuplasty TM 30 CGRP 30 CXCL# 30 pleurodesis 30 ALGRX 30 Simulect 30 Acute Coronary Syndromes ACS 30 RMO 30 tricalcium phosphate 30 Hitrans 30 ANQ 30 Zysolin TM 30 BMAC System 30 PI3K Akt 30 CDISC ODM 30 overactive bladder syndrome 30 receptor inhibitor 30 bone morphogenetic proteins 30 mice overexpressing 30 USARCENT 30 Apolipoprotein 30 Rapid Aerostat Initial 30 Interferon beta 30 confirmatory Phase